We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Immune System Memory Linked to Interferon Alpha Activity

By LabMedica International staff writers
Posted on 15 Dec 2008
Immunologists have found that the ability of the human immune system to "remember” battling a specific pathogen requires the action of the cytokine, interferon alpha.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA; www.utsouthwestern.edu) sought to trace the molecular mechanism that enables a small cadre of immune T cells to "remember” the structure of viruses and bacteria that have been attacked and eliminated by the immune system. More...
Of primary interest was the role of interferon alpha, a cytokine secreted by immune cells shortly after infection.

They reported in the December 15, 2008, issue of the Journal of Immunology, that the effects of interferon alpha were linked to the activities of two other molecules, the interleukins IL-2 and IL-12. After infection by an unknown pathogen, immune cells begin to secrete IL-12, which triggers the immune response and alerts other types of immune cells to attack the invaders. At the same time, IL-12 inhibits the activity of IL-2, which is required for immune cells to "remember” the identity of the pathogen. Now, interferon alpha enters the picture. Interferon and IL-12 work together to generate a special subset of cells that secrete IL-2. It is these IL-2-secreting cells that remain in the body and "remember” how to fight off the invader.

"Without the IL-2 signaling protein, you will generate a beautiful primary response against a virus, and you will eliminate the bug, but your body will not remember how it defeated the virus,” explained senior author Dr. David Farrar, assistant professor of immunology at the University of Texas Southwestern Medical Center. "Without these memory cells, your body is defenseless against reinfections.”

In this study, we have uncovered interferon's role and the key signaling protein, called IL-2, involved in generating memory T cells,” said Dr. Farrar. "Knowing how T cells acquire this memory may help us design better strategies and vaccines to fight HIV and other infectious diseases.

Related Links:

University of Texas Southwestern Medical Center

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.